Cargando…
Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547877/ https://www.ncbi.nlm.nih.gov/pubmed/37799595 http://dx.doi.org/10.3389/or.2023.11471 |
_version_ | 1785115152273637376 |
---|---|
author | Nemunaitis, John Stanbery, Laura Walter, Adam Rocconi, Rodney Stephens, Philip |
author_facet | Nemunaitis, John Stanbery, Laura Walter, Adam Rocconi, Rodney Stephens, Philip |
author_sort | Nemunaitis, John |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10547877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105478772023-10-05 Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer Nemunaitis, John Stanbery, Laura Walter, Adam Rocconi, Rodney Stephens, Philip Oncol Rev Health Archive Frontiers Media S.A. 2023-09-20 /pmc/articles/PMC10547877/ /pubmed/37799595 http://dx.doi.org/10.3389/or.2023.11471 Text en Copyright © 2023 Nemunaitis, Stanbery, Walter, Rocconi and Stephens. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Health Archive Nemunaitis, John Stanbery, Laura Walter, Adam Rocconi, Rodney Stephens, Philip Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer |
title | Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer |
title_full | Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer |
title_fullStr | Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer |
title_full_unstemmed | Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer |
title_short | Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer |
title_sort | rationale for the use of homologous recombination proficient molecular profile as a biomarker for therapeutic targeting in ovarian cancer |
topic | Health Archive |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547877/ https://www.ncbi.nlm.nih.gov/pubmed/37799595 http://dx.doi.org/10.3389/or.2023.11471 |
work_keys_str_mv | AT nemunaitisjohn rationalefortheuseofhomologousrecombinationproficientmolecularprofileasabiomarkerfortherapeutictargetinginovariancancer AT stanberylaura rationalefortheuseofhomologousrecombinationproficientmolecularprofileasabiomarkerfortherapeutictargetinginovariancancer AT walteradam rationalefortheuseofhomologousrecombinationproficientmolecularprofileasabiomarkerfortherapeutictargetinginovariancancer AT rocconirodney rationalefortheuseofhomologousrecombinationproficientmolecularprofileasabiomarkerfortherapeutictargetinginovariancancer AT stephensphilip rationalefortheuseofhomologousrecombinationproficientmolecularprofileasabiomarkerfortherapeutictargetinginovariancancer |